Global High Content Screening Market Set For Robust Growth, To Reach Around USD 1,228.8 Million by 2025

Zion Market Research has published a new report titled “High Content Screening Market by Product (Services, Software, Accessories, Consumables and Instruments); by Application (Compound Profiling, Toxicity Studies, Target Identification and Validation, Primary and Secondary Screening and Other Applications); by End User (Research Institutes, Contract Research Organizations (CROs) and Pharmaceutical and Biotechnology Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2025”. According to the report, global demand for high content screening market was valued at approximately USD 648.7 million in 2018, and is expected to generate revenue of around USD 1,228.8 million by end of 2025, growing at a CAGR of around 9.6% between 2019 and 2025.

Browse the full “High Content Screening Market: by Product (Services, Software, Accessories, Consumables and Instruments); by Application (Compound Profiling, Toxicity Studies, Target Identification and Validation, Primary and Secondary Screening and Other Applications); by End User (Research Institutes, Contract Research Organizations (CROs) and Pharmaceutical and Biotechnology Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025” Report at https://www.zionmarketresearch.com/report/high-content-screening-market

High content screening (HCS) or high content analysis (HCA) is screening approach to cell biology that involves quantitative data analysis in a high-throughput format using automated imaging for large-scale applications like systems biology and drug discovery. High content screening involves real time readout of various parameters to detect cell phenotype alteration by small molecules, RNAi or peptides. High content screening is strictly high in content and low in throughput unlike high throughput screening. 

Worldwide technological advancements in the cell imaging instruments and solutions in terms of quality and efficiency drive the high content screening market growth. Additionally, growing need to minimize pharmaceutical R&D costs, favorable research grants from government, advancements in informatics solutions and imaging instruments, and venture capital investments are factors that support the market growth. However, lower adoption rate of high content screening due to higher cost of instruments may act as a restraining factor for the market growth. Surge in high content screening outsourcing services by CROs and potential use of high content screening in precision medicine are expected to bring new growth avenues for major market players of high content screening. 

Global high content screening market is segmented based on product, technology, application, end user and region. Based on product, market is categorized into software, services, consumables, accessories, and instruments. Software segment is expected to grow at a highest CAGR in the coming years. The instruments segment was the largest product segment in 2018 due to factors such as high price of instruments, technological advancements and automation in instrumentation. Instruments segment is sub categorized into cell imaging and analysis systems and flow cytometers.

Based on applications market is segmented into toxicity studies, compound profiling, primary and secondary screening target identification and validation, and other applications. Target identification and validation is an important and crucial step during drug discovery process. Target identification and validation can help minimize the drug attrition rate in later stages of clinical trials and also financial losses. Thus Target identification and validation is a must step for drug discovery process and thus accounted for largest market share in 2018 whereas primary and secondary screening segment is projected to register rapid growth in the coming years.

The end user segment is divided into contract research organizations (CROs), research institutes and pharmaceutical and biotechnology companies. Pharmaceutical and biotechnology companies accounted for largest market share in 2018 for high content screening market whereas CROs are projected to register rapid growth during the forecast period. Increasing adoption of high content screening technologies is the major driving factor for this growth.

North America was the largest regional market in global high content screening in 2018. Growing focus on novel drug development by major pharmaceutical and biopharmaceutical companies, availability of funds, growing investments on R&D, increasing demand for precision medicine, technological advancements and availability of developed R&D infrastructure are factors driving the market in this region. Europe was second largest regional market. Presence of developed infrastructure, government initiatives and rise in R&D expenditure for drug discovery and development services are some of factors that boost market growth in this region. Latin America is estimated to witness moderate growth over the forecast period. Asia Pacific region will register rapid growth for high content screening market in the coming years. Emphasis on capturing growth opportunities and business expansion in emerging Asian countries by major contract research organizations, government initiatives to enhance drug discovery research and improve infrastructure, rapidly expanding pharmaceutical and biopharmaceutical research industry in China and India are factors supporting high content screening market growth in Asia Pacific. Middle East and Africa may see slower growth in forecasted period due to lack of infrastructure and funds.

Major players included in the report are Bio-Rad Laboratories, Yokogawa Electric Corporation, BioTek Instruments Inc., Becton, Dickinson and Company, PerkinElmer, Inc., Tecan Group, Danaher Corporation, Thermo Fisher Scientific, Inc., GE Healthcare and Merck Millipore among others.

The report segment of global high content screening market as follows:

Global High Content Screening Market: By Product

• Instruments
  • Cell Imaging and Analysis Systems
  • Flow Cytometers
• Consumables
• Software
• Services
• Accessories

Global High Content Screening Market: By Application

• Target Identification and Validation
• Primary Screening and Secondary Screening
• Toxicity Studies
• Compound Profiling
• Other Applications

Global High Content Screening Market: By End User

• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Contract Research Organizations (CROs)

Global High Content Screening Market: By Region

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com